![](/img/cover-not-exists.png)
2. A randomized, double-blind, multicentre crossover trial to evaluate in vivo inhibition of aromatase by Arimidex (ZD1033) (1 mg and 10 mg PO OD) in postmenopausal women with breast cancer
J. Geisler, P.E. Lonning, M. Dowsett, N. King, S. Lundgren, L. Ottestad, P.O. Kormeset, P.L. WaltonVolume:
4
Year:
1995
Language:
english
DOI:
10.1016/0960-9776(95)90094-2
File:
PDF, 290 KB
english, 1995